Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ICODEXTRIN vs IDARUBICIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ICODEXTRIN vs IDARUBICIN: Safety Overview

Metric ICODEXTRIN IDARUBICIN
Total FAERS Reports 253 5,038
Deaths Reported 70 1,260
Death Rate 27.7% 25.0%
Hospitalizations 147 1,856
Average Patient Age 63.1 yrs 44.8 yrs
% Female Patients 42.7% 46.2%
FDA Approval Date Dec 20, 2002 Apr 25, 1995
Manufacturer N/A Pfizer Laboratories Div Pfizer Inc
Route N/A INTRAVENOUS
Marketing Status Prescription Discontinued